The effects of tissue sealants, platelet gels, and growth factors on wound healing

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 11, Issue 4, 2003, Pages 245-250

  Brissett, Anthony E ^a   Hom, David B ^b,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECAPLERMIN; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SEALANT;

CELL PROLIFERATION; COLONY FORMING UNIT; GEL; HEMOSTASIS; PRIORITY JOURNAL; REVIEW; SKIN FLAP; SKIN INCISION; THROMBOCYTE AGGREGATION; WOUND CARE; WOUND HEALING;

BLOOD PLATELETS; GELS; GROWTH SUBSTANCES; HEAD; HUMANS; NECK; TISSUE ADHESIVES; WOUND HEALING; WOUNDS AND INJURIES;

EID: 0038148069     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/00020840-200308000-00005     Document Type: Review

References (31)

1. Gorti G, Ronson S, Koch RJ: Wound healing. Facial Plast Surg Clin N Am, 2002, 10:119-127. This article provides an excellent review of the biology related to wound healing with an emphasis on growth factors.
2. Brissett AE, Sherris DA: Scar contractures, hypertrophic scars, and keloids. Facial Plast Surg 2001, 17:263-272.
3. Hom DB, Thatcher G, Tibesar R: Growth factor therapy to improve soft tissue healing. Facial Plast Surg 2002, 18:41-52. This article describes the recent progress related to the use of growth factors on soft tissue structures within the head and neck.
4. Man D, Plosker H, Winland-Brown JE: The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg 2001, 107:229-237; discussion 238-239. This article reports on the technique of harvesting and preparing autologous platelet gels and fibrin glue. In addition, it compares their effectiveness in stopping capillary bleeding in surgical flaps.
5. Matras H: Die Wirkungen vershiedener Fibrinpraparate auf Kontinuitatstrennungen der Rattenhaut. Osterr Z Stomatol 1970, 338.
6. Bhanot S, Alex JC: Current applications of platelet gels in facial plastic surgery. Facial Plast Surg 2002, 18:27-33. A good review of the preparation and applications of platelet gels for head and neck surgery.
7. Walshe P: The use of fibrin glue to arrest epistaxis in the presence of a coagulopathy. Laryngoscope 2002, 112:1126-1128.
8. Fezza JP, et al.: The use of aerosolized fibrin glue in face-lift surgery. Plast Reconstr Surg 2002, 110:658-664; discussion 665-656. This study reports on the use of aerosolized fibrin glue in 48 patients undergoing facelift surgery. The amount of bruising, edema, and complications as well as operating time are assessed in this study.
9. Gosain AK, Lyon VB: The current status of tissue glues: part II. For adhesion of soft tissues. Plast Reconstr Surg 2002, 110:1581-1584.
10. Siedentop KH, et al.: Safety and efficacy of currently available fibrin tissue adhesives. Am J Otolaryngol 2001, 22:230-235. This study provides a concise comparison of preparation methods, preparation time, bonding power, and costs associated with currently available autologous and homologous fibrin tissue adhesives.
11. Byrne DJ, et al.: Effect of fibrin glues on the mechanical properties of healing wounds. Br J Surg 1991, 78:841-843.
12. O'Grady KM, et al.: An evaluation of fibrin tissue adhesive concentration and application thickness on skin graft survival. Laryngoscope 2000, 110:1931-1935.
13. Mandracchia VJ, Sanders SM, Frerichs JA: The use of becaplermin (rhPDGF-BB) gel for chronic nonhealing ulcers. A retrospective analysis. Clin Podiatr Med Surg 2001, 18:189-209, viii. This article discusses the effects of platelet-derived growth factor-BB on the wound healing process with emphasis on the inflammatory stage of wound healing as well as principles of wound care.
14. Hom DB: Growth factors in wound healing. Otolaryngol Clin North Am 1995, 28:933-953.
15. Bauer EA, et al.: Stimulation of in vitro human skin collagenase expression by platelet- derived growth factor. Proc Natl Acad Sci U S A 1985, 82:4132-4136.
16. Marx RE: Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent 2001, 10:225-228. This review discusses the definition of PRP, its safety, development, and its most efficacious means of application.
17. Powell DM, Chang E, Farrior EH: Recovery from deep-plane rhytidectomy following unilateral wound treatment with autologous platelet gel: a pilot study. Arch Facial Plast Surg 2001, 3:245-250.
18. Embil JM, et al.: Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open-label clinical evaluation of efficacy. Wound Repair Regen 2000, 8:162-168.
19. LeGrand EK: Preclinical promise of becaplermin (rhPDGF-BB) in wound healing. Am J Surg 1998, 176(suppl):48S-54S.
20. Steed DL: Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group. J Vasc Surg 1995, 21:71-78; discussion 79-81.
21. Wieman TJ, Smiell JM, Su Y: Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo- controlled double-blind study. Diabetes Care 1998, 21:822-827.
22. Wieman TJ: Clinical efficacy of becaplermin (rhPDGF-BB) gel. Becaplermin Gel Studies Group. Am J Surg 1998, 176(suppl): 74S-79S.
23. Smiell JM, et al.: Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen 1999, 7:335-346.
24. Robson MC, Mustoe TA, Hunt TK: The future of recombinant growth factors in wound healing. Am J Surg 1998, 176(suppl):80S-82S.
25. Perry BH, et al.: A meta-analytic approach to an integrated summary of efficacy: a case study of becaplermin gel. Control Clin Trials 2002, 23:389-408.
26. Wollina U, Liebold K, Konrad H: Treatment of chronic radiation ulcers with recombinant platelet-derived growth factor and a hydrophilic copolymer membrane. J Eur Acad Dermatol Venereol 2001, 15:455-457.
27. Mast B: Complementary effects of becaplermin gel and HBO in an irradiated wound. Wound Repair Regen 2002, 10:A37.
28. Hom DB, Manivel C: Promoting healing with rhPDGF in a previously irradiated problem wound. Laryngoscope 2003, in press.
29. Li VW, et al.: Off-label dermatologic therapies. Usage, risks, and mechanisms. Arch Dermatol 1998, 134:1449-1454.
30. Steed DL: Effects of extensive debridement and treatment on the healing of diabetic foot ulcers. J Am Coll Surg 1996, 183.
31. Steed DL: Modifying the wound healing response with exogenous growth factors. Clin Plast Surg 1998, 25:397-405.